Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action.

Autor: Sheridan, Douglas1 douglas.sheridan@alexion.com, Yu, Zhao-Xue1, Zhang, Yuchun1, Patel, Rekha2, Sun, Fang1, Lasaro, Melissa A.1, Bouchard, Keith1, Andrien, Bruce3, Marozsan, Andre1, Wang, Yi1, Tamburini, Paul1
Zdroj: PLoS ONE. 4/12/2018, Vol. 13 Issue 4, p1-15. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje